Crossmark

A centralised immunogen approach to develop a more broadly protective modified live porcine reproductive and respiratory syndrome virus 1 vaccine candidate

Crossref DOI link: https://doi.org/10.1038/s41541-025-01192-z

Published Online: 2025-06-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

de Brito, Rory C. F.

Sadigh, Yashar

Bowman, Joseph

Clive, Stephanie

Jackson, Ben

Pedrera, Miriam

Crofts, Fraser

Bernard, Matthieu

Lean, Fabian Z. X.

Núñez, Alejandro

Seago, Julian

Frossard, Jean-Pierre

Graham, Simon P.
Funding

Funding for this research was provided by:

Biotechnology and Biological Sciences Research Council (BBS/E/I/00007031, BBS/E/I/00007031, BBS/E/I/00007031, BBS/E/I/00007031, BBS/E/I/00007031, BBS/E/I/00007031, BBS/E/I/00007031, BBS/E/I/00007031)

Huvepharma
License Information

Text and Data Mining valid from 2025-06-21

Version of Record valid from 2025-06-21
More Information

Article History

Received: 26 February 2025

Accepted: 11 June 2025

First Online: 21 June 2025

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below